aod9604 recommended dosage for fat loss AOD 9604 Peptide Loss: Does It Work? AOD-9604 Peptide: A Comprehensive Guide

Current Cardiology Reviews, 9(1), 3354

Reducing by 50-100mcg often resolves these issues while maintaining effectiveness

Primary injection sites for AOD-9604 include the abdominal area (around the navel, varying position each injection), the front of the thighs (alternating legs), and the back of the upper arms (alternating arms)

peptide clinics and compounding pharmacies make AOD9604 available, but its typically labeled for research purposes only to comply with DSHEA (Dietary Supplement Health and Education Act) regulations (FDA compounding context)

At 300 mcg, which is the standard current protocol, the effect size is likely more modest still

Why Fasted Administration Matters AOD-9604 stimulates lipolysis through beta-3 adrenergic receptor activation, promoting the release of stored fatty acids for energy utilization